Advanced search
Publication Cover
Brain Injury Volume 6, 1992 - Issue 3
Submit an article Journal homepage
69
Views
72
CrossRef citations to date
0
Altmetric
Original Article

Fluoxetine improves emotional incontinence

Glenn M. Seliger Department of Neurology, Helen Hayes Hospital, West Haverstraw, New York; Department of Neurology, Columbia University College of Physicians and Surgeons, New York
,
Andrew Hornstein Department of Psychiatry and Behavioral Medicine, Helen Hayes Hospital, West Haverstraw, New York; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York
,
James Flax Department of Psychiatry and Behavioral Medicine, Helen Hayes Hospital, West Haverstraw, New York; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York
,
Joseph Herbert Department of Neurology, Helen Hayes Hospital, West Haverstraw, New York; Department of Neurology, Columbia University College of Physicians and Surgeons, New York
&
Karl Schroeder Department of Psychiatry and Behavioral Medicine, Helen Hayes Hospital, West Haverstraw, New York; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York
Pages 267-270 | Received 29 Mar 1991, Accepted 04 May 1991, Published online: 03 Jul 2009

Citations (72)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Marian W. Roman. (2015) NueDexta: A Treatment for Pseudobulbar Affect. Issues in Mental Health Nursing 36:12, pages 1019-1021.
Read now
Aiesha Ahmed & Zachary Simmons. (2013) Pseudobulbar affect: prevalence and management. Therapeutics and Clinical Risk Management 9, pages 483-489.
Read now
Rebecca R King & Jeffrey P Reiss. (2013) The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration. Degenerative Neurological and Neuromuscular Disease 3, pages 23-31.
Read now
Ariel Miller, Hillel Pratt & Randolph B Schiffer. (2011) Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Review of Neurotherapeutics 11:7, pages 1077-1088.
Read now
Stephanie H Ameis & Anthony Feinstein. (2006) Treatment of neuropsychiatric conditions associated with multiple sclerosis. Expert Review of Neurotherapeutics 6:10, pages 1555-1567.
Read now
Hochang B. Lee, Constantine G. Lyketsos & Vani Rao. (2003) Pharmacological management of the psychiatric aspects of traumatic brain injury. International Review of Psychiatry 15:4, pages 359-370.
Read now
Jay M. Meythaler, Lawrence Depalma, Michael J. Devivo, Sharon Guin-Renfroe, Thomas A. Novack. (2001) Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Injury 15:4, pages 321-331.
Read now
Ulrich Muller, Toshiya Murai, Thomas Bauer-Wittmund & D. Yves Von Cramon. (1999) Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Injury 13:10, pages 805-811.
Read now
Frances L. Dark, John J. McGrath & Maria A. Ron. (1996) Pathological laughing and crying. Australian and New Zealand Journal of Psychiatry 30:4, pages 472-479.
Read now
Andrew Hornstein, Glenn Seliger, James Flax, Joseph Herbert & Karl Schroeder. (1993) Letter to the Editors: Fluoxetine in treating emotional lability. Brain Injury 7:2, pages 189-189.
Read now

Articles from other publishers (62)

Sabine Allida, Allan House & Maree L Hackett. (2022) Pharmaceutical interventions for emotionalism after stroke. Cochrane Database of Systematic Reviews 2022:11.
Crossref
Michael J. Gigliotti, Pardis Pooshpas, Neel Patel & Elias B. Rizk. (2021) A male patient with pseudobulbar affect caused by post-traumatic normal pressure hydrocephalus successfully managed with ventriculoperitoneal shunt. Interdisciplinary Neurosurgery 23, pages 100916.
Crossref
Sabine Allida, Kulsum Patel, Allan House & Maree L Hackett. (2019) Pharmaceutical interventions for emotionalism after stroke. Cochrane Database of Systematic Reviews.
Crossref
Sang Hoon Shin, Yong Wook Kim & Na Young Kim. (2019) Treatment of Poststroke Pathologic Laughing With Duloxetine: A Case Series. Clinical Neuropharmacology 42:2, pages 60-63.
Crossref
Anthony Feinstein & Bennis Pavisian. 2017. Health Issues in Women with Multiple Sclerosis. Health Issues in Women with Multiple Sclerosis 97 106 .
Frederick W. Foley. 2015. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases 107 119 .
Kendra Campbell, Ramaswamy Viswanathan & Ramotse Saunders. (2014) Dextromethorphan/quinidine for pseudobulbar affect associated with subarachnoid hemorrhage. Future Neurology 9:3, pages 295-300.
Crossref
Edna Patatanian & Jessica Casselman. (2014) Dextromethorphan/Quinidine for the Treatment of Pseudobulbar Affect. The Consultant Pharmacist 29:4, pages 264-269.
Crossref
Ahmed Toosy, Olga Ciccarelli & Alan Thompson. 2014. Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders 513 562 .
Akira Kishimoto, Katsusuke Yatomi, Yoshitaka Yokoyama, Naoko Nakatsu, Kazuaki Fujita & Kenji Hashimoto. (2013) Ifenprodil for Emotional Incontinence in Patients With Vascular Dementia. Journal of Clinical Psychopharmacology 33:1, pages 143-145.
Crossref
Leslie J. Blackhall. (2012) Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead. Muscle & Nerve 45:3, pages 311-318.
Crossref
Apostolos Iacovides & Elias Andreoulakis. (2011) Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review. Current Opinion in Psychiatry 24:4, pages 336-340.
Crossref
Erik P. Pioro. (2011) Current Concepts in the Pharmacotherapy of Pseudobulbar Affect. Drugs 71:9, pages 1193-1207.
Crossref
Erik P. Pioro, Benjamin Rix Brooks, Jeffrey Cummings, Randolph Schiffer, Ronald A. Thisted, Daniel Wynn, Adrian Hepner & Randall Kaye. (2010) Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect. Annals of Neurology 68:5, pages 693-702.
Crossref
Anthony Feinstein & Omar Ghaffar. 2011. Multiple Sclerosis. Multiple Sclerosis 183 189 .
. 2011. Multiple Sclerosis. Multiple Sclerosis 165 239 .
P. Kraft, M. Beck, A. Grimm, C. Wessig, K. Reiners & K.V. Toyka. (2010) Amyotrophe LateralskleroseAmyotrophic lateral sclerosis. Der Nervenarzt 81:10, pages 1218-1225.
Crossref
Roy E. Strowd, Michael S. Cartwright, Michael S. Okun, Ihtsham Haq & Mustafa S. Siddiqui. (2010) Pseudobulbar affect: prevalence and quality of life impact in movement disorders. Journal of Neurology 257:8, pages 1382-1387.
Crossref
Maree L Hackett, Michelle Yang, Craig S Anderson, Judith A Horrocks & Allan House. (2010) Pharmaceutical interventions for emotionalism after stroke. Cochrane Database of Systematic Reviews.
Crossref
Jonathan Price, Victoria Cole & Guy M. Goodwin. (2018) Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. British Journal of Psychiatry 195:3, pages 211-217.
Crossref
Ida S. Haussleiter, Martin Brüne & Georg Juckel. (2009) Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Therapeutic Advances in Neurological Disorders 2:1, pages 13-29.
Crossref
Ruth Elaine Nieuwenhuis-Mark, Anneke van Hoek & Ad Vingerhoets. (2008) Understanding Excessive Crying in Neurologic Disorders: Nature, Pathophysiology, Assessment, Consequences, and Treatment. Cognitive and Behavioral Neurology 21:2, pages 111-123.
Crossref
Preethi Balakrishnan & Howard Rosen. (2008) The causes and treatment of pseudobulbar affect in ischemic stroke. Current Treatment Options in Cardiovascular Medicine 10:3, pages 216-222.
Crossref
Jeffrey A. Wilken & Cynthia Sullivan. (2007) Recognizing and Treating Common Psychiatric Disorders in Multiple Sclerosis. The Neurologist 13:6, pages 343-354.
Crossref
Hal S. Wortzel, C. Alan Anderson & David B. Arciniegas. (2008) Treatment of pathologic laughing and crying. Current Treatment Options in Neurology 9:5, pages 371-380.
Crossref
Hal S. Wortzel, C. Alan Anderson & David B. Arciniegas. (2007) Treatment of pathologic laughing and crying. Current Treatment Options in Neurology 9:5, pages 371-380.
Crossref
Gale Robinson-Smith & Joshua D. Grill. (2007) Recognizing Involuntary Emotional Expression Disorder. Journal of Neuroscience Nursing 39:4, pages 202-207.
Crossref
Anthony Feinstein. 2009. The Clinical Neuropsychiatry of Multiple Sclerosis. The Clinical Neuropsychiatry of Multiple Sclerosis 82 98 .
Anthony Feinstein. (2007) Neuropsychiatric syndromes associated with multiple sclerosis. Journal of Neurology 254:S2, pages II73-II76.
Crossref
Jörg Holenz, José Luis Díaz & Helmut Buschmann. 2007. Antidepressants, Antipsychotics, Anxiolytics. Antidepressants, Antipsychotics, Anxiolytics 173 296 .
Jan Schindehütte & Claudia Trenkwalder. (2007) Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. Clinical Neurology and Neurosurgery 109:2, pages 188-191.
Crossref
Howard J. Rosen & Jeffrey Cummings. (2007) A real reason for patients with pseudobulbar affect to smile. Annals of Neurology 61:2, pages 92-96.
Crossref
Benjamin Rix Brooks. (2014) Involuntary Emotional Expression Disorder: Treating the Untreated. CNS Spectrums 12:S5, pages 23-27.
Crossref
John E. Duda. (2014) History and Prevalence of Involuntary Emotional Expression Disorder. CNS Spectrums 12:S5, pages 6-10.
Crossref
Josef Parvizi, David B. Arciniegas, Gary L. Bernardini, Michael W. Hoffmann, Jay P. Mohr, Mark J. Rapoport, Jeremy D. Schmahmann, Jonathan M. Silver & Stanley Tuhrim. (2006) Diagnosis and Management of Pathological Laughter and Crying. Mayo Clinic Proceedings 81:11, pages 1482-1486.
Crossref
Kate Jefferies. (2018) The neuropsychiatry of multiple sclerosis. Advances in Psychiatric Treatment 12:3, pages 214-220.
Crossref
L.M. Chahine & Z. Chemali. (2006) Du rire aux larmes: Pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine. Epilepsy & Behavior 8:3, pages 610-615.
Crossref
David C. Mohr & Darcy Cox. 2006. Psychiatry for Neurologists. Psychiatry for Neurologists 177 189 .
Daniel Weintraub. (2005) Therapeutic options for emotional lability: Current and emerging treatments. The American Journal of Geriatric Pharmacotherapy 3, pages 12-15.
Crossref
Arlene Kasprisin. (2004) Alternative cognitive therapy for emotional instability (pathologic laughing and crying). Physical Medicine and Rehabilitation Clinics of North America 15:4, pages 883-917.
Crossref
Anthony Feinstein. (2004) The Neuropsychiatry of Multiple Sclerosis. The Canadian Journal of Psychiatry 49:3, pages 157-163.
Crossref
Barbara Wild, Frank A. Rodden, Wolfgang Grodd & Willibald Ruch. (2003) Neural correlates of laughter and humour. Brain 126:10, pages 2121-2138.
Crossref
Ross D. Zafonte, Nora Cullen & Jan Lexell. (2002) Serotonin Agents in the Treatment of Acquired Brain Injury. Journal of Head Trauma Rehabilitation 17:4, pages 322-334.
Crossref
M.L.C. Labi. (2002) Tratamiento neurofarmacológico tras un traumatismo craneoencefálico. Rehabilitación 36:6, pages 364-372.
Crossref
U. Müller. (2001) Pharmakotherapie emotionaler Störungen bei Patienten mit erworbener Hirnschädigung. Zeitschrift für Neuropsychologie 12:4, pages 336-349.
Crossref
Anthony Feinstein & Karen Feinstein. (2001) Depression associated with multiple sclerosis. Journal of Affective Disorders 66:2-3, pages 193-198.
Crossref
Pieter Joost van Wattum & Catherine Chiles. (2001) Rapid response to low dose citalopram in pathological crying. General Hospital Psychiatry 23:3, pages 167-168.
Crossref
David C. Mohr & Darcy Cox. (2001) Multiple sclerosis: Empirical literature for the clinical health psychologist. Journal of Clinical Psychology 57:4, pages 479-499.
Crossref
Steven R. Flanagan. (2014) Psychostimulant Treatment of Stroke and Brain Injury. CNS Spectrums 5:3, pages 59-69.
Crossref
L.M Metz, S.B Patten & D McGowan. (1999) Symptomatic therapies of multiple sclerosis. Biomedicine & Pharmacotherapy 53:8, pages 371-379.
Crossref
K. W. Brown, R. L. Sloan & B. Pentland. (1998) Fluoxetine as a treatment for post-stroke emotionalism. Acta Psychiatrica Scandinavica 98:6, pages 455-458.
Crossref
Ida Wikander, Charlotta Sundblad, Bjorn Andersch, Inger Dagnell, Dimitri Zylberstein, Finn Bengtsson & Elias Eriksson. (1998) Citalopram in Premenstrual Dysphoria. Journal of Clinical Psychopharmacology 18:5, pages 390-398.
Crossref
R. Torta, A. Cicolin & R. Keller. (1998) Stroke and depression: clinical features and treatment. The Italian Journal of Neurological Sciences 19:S1, pages S20-S24.
Crossref
Bee Lee Low & Siow Ann Chong. (1998) Treating Poststroke Pathologic Crying With Fluoxetine. Journal of Clinical Psychopharmacology 18:3, pages 252.
Crossref
Melissa Frumin, Terry Chisholm, Chandlee C. Dickey & Kirk R. Daffner. (1998) PSYCHIATRIC AND BEHAVIORAL PROBLEMS. Neurologic Clinics 16:2, pages 521-544.
Crossref
David R. Wiercisiewski & James T. McDeavitt. (1997) Drugs for Management of Acute and Chronic Behavioral Disorders. Physical Medicine and Rehabilitation Clinics of North America 8:4, pages 763-780.
Crossref
I. TAN & M. DOREVITCH. (2008) Emotional incontinence: a dramatic response to paroxetine. Australian and New Zealand Journal of Medicine 26:6, pages 844-844.
Crossref
Kris A. Peterson, Scott Armstrong & Janice Moseley. (1996) Pathologic Crying Responsive to Treatment With Sertraline. Journal of Clinical Psychopharmacology 16:4, pages 333.
Crossref
Mahendra Dave. (1996) Paroxetine for Pathological Crying. The American Journal of Geriatric Psychiatry 4:2, pages 180-181.
Crossref
U. Müller, R. Frieboes & D. Y. von Cramon. 1996. Aktuelle Perspektiven der Biologischen Psychiatrie. Aktuelle Perspektiven der Biologischen Psychiatrie 112 116 .
G. Andersen, K. Vestergaard & M. Ingeman-Nielsen. (1995) Post-stroke pathological crying: frequency and correlation to depression. European Journal of Neurology 2:1, pages 45-50.
Crossref
G. Andersen, K. Vestergaard & J.O. Riis. (1993) Citalopram for post-stroke pathological crying. The Lancet 342:8875, pages 837-839.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.